← Leaderboards
Donald J Zack
Johns Hopkins University
$29,428,568
Attributed
$41,876,680
Total exposure
24
Grants
18
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.8M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$54,607,439 · 25
By mechanism
R01$24,182,368 · 10
P30$13,791,180 · 6
U24$7,258,114 · 1
T32$4,122,517 · 1
U01$2,276,207 · 1
R21$1,769,709 · 4
Top collaborators
- Jiang Qian9 shared
- Jeremy Nathans7 shared
- Amer Riazuddin7 shared
- David J Calkins6 shared
- Jeffrey L Goldberg6 shared
- Vassilis E Koliatsos6 shared
- Thomas A Reh6 shared
- David M Gamm5 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Derek Stuart Welsbie$4,906,220
- Harry Alan Quigley$23,425,626
- Maria Valeria Canto-Soler$4,412,365
- Laura Ensign$10,004,174
- Peter A Calabresi$20,846,075
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseCellsBlindnessProgramsMolecularRetinaBioinformaticsLeadGenesIn VitroTranscription FactorGene ExpressionRetinal Ganglion CellsDesignTechnologyPathway InteractionsIn VivoFundingVisionInsightLaboratoriesSuccessAnimal ModelStructure
Grant awards (135)
Connecting AMD SNPs to Functions Using Allele-specific Interactions$487,947
R01 · FY2025 · EY · contact PI
Role of OPA1 in Retinal Ganglion Cell Differentiation and the Pathogenesis of Dominant Optic Atrophy$347,969
R01 · FY2025 · EY · contact PI
Visual Science Training Program$302,746
T32 · FY2025 · EY · contact PI
Visual Science Training Program$51,288
T32 · FY2025 · EY · contact PI
Connecting AMD SNPs to Functions Using Allele-specific Interactions$490,713
R01 · FY2024 · EY · contact PI
Role of OPA1 in Retinal Ganglion Cell Differentiation and the Pathogenesis of Dominant Optic Atrophy$409,375
R01 · FY2024 · EY · contact PI
Visual Science Training Program$147,297
T32 · FY2024 · EY · contact PI
Administrative Core$20,687
P30 · FY2024 · EY · contact PI
Connecting AMD SNPs to Functions Using Allele-specific Interactions$481,132
R01 · FY2023 · EY · contact PI
Role of OPA1 in Retinal Ganglion Cell Differentiation and the Pathogenesis of Dominant Optic Atrophy$409,375
R01 · FY2023 · EY · contact PI
Visual Science Training Program$243,395
T32 · FY2023 · EY · contact PI
Administrative Core$20,687
P30 · FY2023 · EY · contact PI
Retinal Ganglion Cell Replacement in Optic Neuropathies$1,342,555
U24 · FY2022 · EY
Connecting AMD SNPs to Functions Using Allele-specific Interactions$471,863
R01 · FY2022 · EY · contact PI
Visual Science Training Program$232,412
T32 · FY2022 · EY · contact PI
Administrative Core$20,687
P30 · FY2022 · EY · contact PI
Retinal Ganglion Cell Replacement in Optic Neuropathies$1,357,464
U24 · FY2021 · EY
P30 Wilmer Core Grant for Vision Research$818,750
P30 · FY2021 · EY · contact PI
Traumatic axonal injury in the visual system: role of dual leucine zipper kinase$494,288
R01 · FY2021 · EY
Connecting AMD SNPs to Functions Using Allele-specific Interactions$493,641
R01 · FY2021 · EY · contact PI
Computational Tools for Single Cell Analysis: Application to Retinal Degeneration$397,093
R01 · FY2021 · EY
Retinal Ganglion Cell Replacement in Optic Neuropathies$303,750
U24 · FY2021 · EY
Visual Science Training Program$224,690
T32 · FY2021 · EY · contact PI
Administrative Core$20,687
P30 · FY2021 · EY · contact PI
Retinal Ganglion Cell Replacement in Optic Neuropathies$1,378,189
U24 · FY2020 · EY
P30 Wilmer Core Grant for Vision Research$818,750
P30 · FY2020 · EY · contact PI
Traumatic axonal injury in the visual system: role of dual leucine zipper kinase$509,574
R01 · FY2020 · EY
Axonal mitochondria degradation as the Achilles heel of retinal ganglion cells$443,596
R01 · FY2020 · EY
Computational Tools for Single Cell Analysis: Application to Retinal Degeneration$409,375
R01 · FY2020 · EY
Visual Science Training Program$218,736
T32 · FY2020 · EY · contact PI
Administrative Core$20,687
P30 · FY2020 · EY · contact PI
Retinal Ganglion Cell Replacement in Optic Neuropathies$1,378,143
U24 · FY2019 · EY
P30 Wilmer Core Grant for Vision Research$818,750
P30 · FY2019 · EY · contact PI
Traumatic axonal injury in the visual system: role of dual leucine zipper kinase$509,574
R01 · FY2019 · EY
Axonal mitochondria degradation as the Achilles heel of retinal ganglion cells$443,596
R01 · FY2019 · EY
Computational Tools for Single Cell Analysis: Application to Retinal Degeneration$409,375
R01 · FY2019 · EY
Traumatic axonal injury in the visual system: role of dual leucine zipper kinase$397,059
R01 · FY2019 · EY
Visual Science Training Program$264,251
T32 · FY2019 · EY · contact PI
Administration Core$20,444
P30 · FY2019 · EY · contact PI
Retinal Ganglion Cell Replacement in Optic Neuropathies$1,498,013
U24 · FY2018 · EY
P30 Wilmer Core Grant for Vision Research$810,000
P30 · FY2018 · EY · contact PI
Screening for Molecules that Promote Photoreceptor Synaptogenesis$671,689
U01 · FY2018 · EY · contact PI
Traumatic axonal injury in the visual system: role of dual leucine zipper kinase$509,379
R01 · FY2018 · EY
Axonal mitochondria degradation as the Achilles heel of retinal ganglion cells$443,596
R01 · FY2018 · EY
Computational Tools for Single Cell Analysis: Application to Retinal Degeneration$409,375
R01 · FY2018 · EY
Visual Science Training Program$259,348
T32 · FY2018 · EY · contact PI
Screening for Molecules that Promote Photoreceptor Synaptogenesis$150,000
U01 · FY2018 · EY · contact PI
Administrative Module$8,483
P30 · FY2018 · EY · contact PI
P30 Wilmer Core Grant for Vision Research$810,000
P30 · FY2017 · EY · contact PI
Screening for Molecules that Promote Photoreceptor Synaptogenesis$671,182
U01 · FY2017 · EY · contact PI
Traumatic axonal injury in the visual system: role of dual leucine zipper kinase$505,956
R01 · FY2017 · EY
Axonal mitochondria degradation as the Achilles heel of retinal ganglion cells$443,595
R01 · FY2017 · EY
Visual Science Training Program$255,961
T32 · FY2017 · EY · contact PI
Screening for Molecules that Promote Photoreceptor Synaptogenesis$97,500
U01 · FY2017 · EY · contact PI
Administrative Module$8,483
P30 · FY2017 · EY · contact PI
P30 Wilmer Core Grant for Vision Research$810,000
P30 · FY2016 · EY · contact PI
Screening for Molecules that Promote Photoreceptor Synaptogenesis$685,836
U01 · FY2016 · EY · contact PI
Axonal mitochondria degradation as the Achilles heel of retinal ganglion cells$450,001
R01 · FY2016 · EY
Dual Leucine Zipper Kinase (DLK) as a Mediator of Retinal Ganglion Cell Injury$405,000
R01 · FY2016 · EY · contact PI
Visual Science Training Program$249,774
T32 · FY2016 · EY · contact PI
Administrative Module$8,484
P30 · FY2016 · EY · contact PI
P30 Wilmer Core Grant for Vision Research$810,000
P30 · FY2015 · EY · contact PI
Dual Leucine Zipper Kinase (DLK) as a Mediator of Retinal Ganglion Cell Injury$396,900
R01 · FY2015 · EY · contact PI
Visual Science Training Program$245,398
T32 · FY2015 · EY · contact PI
Administrative Module$8,483
P30 · FY2015 · EY · contact PI
P30 Wilmer Core Grant for Vision Research$810,000
P30 · FY2014 · EY · contact PI
Dual Leucine Zipper Kinase (DLK) as a Mediator of Retinal Ganglion Cell Injury$396,900
R01 · FY2014 · EY · contact PI
Regulation of Rhodopsin Expression$375,001
R01 · FY2014 · EY · contact PI
Visual Neuroscience Training Program$242,185
T32 · FY2014 · EY · contact PI
AMD THERAPY: A Screen for Molecules that Promote RPE Survival and Differentiation$238,140
R21 · FY2014 · EY · contact PI
Sustained-Release of a Novel Neuroprotective Agent for Improved Glaucoma Therapy$150,176
R43 · FY2014 · EY
Administrative Module$8,482
P30 · FY2014 · EY · contact PI
Wilmer Core Grant for Vision Research$772,852
P30 · FY2013 · EY · contact PI
Dual Leucine Zipper Kinase (DLK) as a Mediator of Retinal Ganglion Cell Injury$405,000
R01 · FY2013 · EY · contact PI
Visual Neuroscience Training Program$230,550
T32 · FY2013 · EY · contact PI
AMD THERAPY: A Screen for Molecules that Promote RPE Survival and Differentiation$202,500
R21 · FY2013 · EY · contact PI
An RNAi Screen for Genes that Modulate Retinal Ganglion Cell Survival$153,900
R21 · FY2013 · EY · contact PI
Wilmer Core Grant for Vision Research$790,808
P30 · FY2012 · EY · contact PI
Regulation of Rhodopsin Expression$580,672
R01 · FY2012 · EY · contact PI
An RNAi Screen for Genes that Modulate Retinal Ganglion Cell Survival$283,500
R21 · FY2012 · EY · contact PI
Visual Neuroscience Training Program$190,225
T32 · FY2012 · EY · contact PI
Wilmer Core Grant for Vision Research$1,388,147
P30 · FY2011 · EY · contact PI
Wilmer Core Grant for Vision Research$814,468
P30 · FY2011 · EY · contact PI
Regulation of Rhodopsin Expression$580,672
R01 · FY2011 · EY · contact PI
Visual Neuroscience Training Program$239,804
T32 · FY2011 · EY · contact PI
Wilmer Core Grant for Vision Research$820,299
P30 · FY2010 · EY · contact PI
Regulation of Rhodopsin Expression$584,462
R01 · FY2010 · EY · contact PI
NEURITIN:novel RGC neurotrophic factor and potential target for glaucoma therapy$363,880
R01 · FY2010 · EY · contact PI
Protein kinase inhibitors that promote RGC survival and function$243,540
R21 · FY2010 · EY · contact PI
Visual Neuroscience Training Program$230,203
T32 · FY2010 · EY · contact PI
Wilmer Core Grant for Vision Research$820,543
P30 · FY2009 · EY · contact PI
Regulation of Rhodopsin Expression$571,306
R01 · FY2009 · EY · contact PI
Regulation of Rhodopsin Expression$463,059
R01 · FY2009 · EY · contact PI
NEURITIN:novel RGC neurotrophic factor and potential target for glaucoma therapy$369,000
R01 · FY2009 · EY · contact PI
Visual Neuroscience Training Program$294,254
T32 · FY2009 · EY · contact PI
Protein kinase inhibitors that promote RGC survival and function$205,000
R21 · FY2009 · EY · contact PI
CORE GRANT FOR VISION RESEARCH$817,392
P30 · FY2008 · EY · contact PI
Visual Neurons--Development and Regeneration In Vitro$633,058
R01 · FY2008 · EY · contact PI
Regulation of Rhodopsin Expression$554,668
R01 · FY2008 · EY · contact PI
CORE--BIOINFORMATICS$203,440
P30 · FY2008 · EY · contact PI
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)$120,710
U10 · FY2008 · EY · contact PI
Regulation of Rhodopsin Expression$75,000
R01 · FY2008 · EY · contact PI
Visual Neurons--Development and Regeneration In Vitro$627,274
R01 · FY2007 · EY · contact PI
REGULATION OF RHODOPSIN GENE EXPRESSION$253,424
R01 · FY2007 · EY · contact PI
Novel Factors Promoting Retinal Ganglion Cell Growth$238,806
R21 · FY2007 · EY · contact PI
CORE--BIOINFORMATICS$201,139
P30 · FY2007 · EY · contact PI
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)$118,062
U10 · FY2007 · EY · contact PI
REGULATION OF RHODOPSIN GENE EXPRESSION$105,126
R01 · FY2007 · EY · contact PI
REGULATION OF RHODOPSIN GENE EXPRESSION$64,324
R01 · FY2007 · EY · contact PI
REGULATION OF RHODOPSIN GENE EXPRESSION$709,537
R01 · FY2006 · EY · contact PI
Novel Factors Promoting Retinal Ganglion Cell Growth$204,323
R21 · FY2006 · EY · contact PI
CORE--BIOINFORMATICS$163,353
P30 · FY2006 · EY · contact PI
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)$115,491
U10 · FY2006 · EY · contact PI
REGULATION OF RHODOPSIN GENE EXPRESSION$708,961
R01 · FY2005 · EY
CORE--BIOINFORMATICS$162,293
P30 · FY2005 · EY
REGULATION OF RHODOPSIN GENE EXPRESSION$150,000
R01 · FY2005 · EY
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)$114,796
U10 · FY2005 · EY
REGULATION OF RHODOPSIN GENE EXPRESSION$70,208
R01 · FY2005 · EY
REGULATION OF RHODOPSIN GENE EXPRESSION$518,007
R01 · FY2004 · EY
ANALYSIS OF HUMAN VMD2: A MODEL FOR RPE GENE REGULATION$367,875
R01 · FY2004 · EY
CORE--BIOINFORMATICS$163,902
P30 · FY2004 · EY
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)$115,014
U10 · FY2004 · EY
REGULATION OF RHODOPSIN GENE EXPRESSION$505,065
R01 · FY2003 · EY
ANALYSIS OF HUMAN VMD2: A MODEL FOR RPE GENE REGULATION$327,000
R01 · FY2003 · EY
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)$130,466
U10 · FY2003 · EY
ANALYSIS OF HUMAN VMD2: A MODEL FOR RPE GENE REGULATION$504,821
R01 · FY2002 · EY
REGULATION OF RHODOPSIN GENE EXPRESSION$490,353
R01 · FY2002 · EY
ANALYSIS OF HUMAN VMD2: A MODEL FOR RPE GENE REGULATION$389,467
R01 · FY2002 · EY
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)$127,217
U10 · FY2002 · EY
REGULATION OF RHODOPSIN GENE EXPRESSION$390,337
R01 · FY2001 · EY
ANALYSIS OF HUMAN VMD2: A MODEL FOR RPE GENE REGULATION$327,417
R01 · FY2001 · EY
ANALYSIS OF HUMAN VMD2: A MODEL FOR RPE GENE REGULATION$172,179
R01 · FY2001 · EY
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)$109,018
U10 · FY2001 · EY
REGULATION OF RHODOPSIN GENE EXPRESSION$378,968
R01 · FY2000 · EY
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)$106,394
U10 · FY2000 · EY